Published in Vaccine Weekly, January 25th, 2006
According to recent research published in the European Journal of Immunology, "Novel approaches for the prevention of allergy are required, because of the inevitably increasing prevalence of allergic diseases during the last 30 years."
Fariba Karamloo at the Swiss Institute of Allergy and Asthma Research and collaborators throughout the world announced, "A recombinant chimeric protein, which comprises the whole amino acid sequences of three bee venom major allergens has been engineered and used in prevention of bee venom...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly